Arno Buecker

TL;DR: Late-enhancement MSCT appears to be as reliable as delayed contrast-enhanced MRI in assessing infarct size and myocardial viability in acute MI.

TL;DR: The feasibility of MRI of coronary thrombus and in-stent thrombosis using a novel fibrin-binding molecular MR contrast agent is demonstrated and potential applications include detection of coronary in-Stent thROMbosis or throm bus burden in patients with acute coronary syndromes.

TL;DR: A new, ultrafast, real-time MR imaging technique that combines steady-state free precession for high signal-to-noise ratio and radial k-space sampling (rSSFP) for motion artifact suppression was implemented on a 1-T clinical whole-body interventional MR scanner and reliably allowed for high-quality coronary MR fluoroscopy without motion artifacts in all pigs.

TL;DR: Calculation of signal attenuation and observation of signal characteristics allowed differentiation of benign fracture edema and tumor infiltration and provided excellent distinction between benign and malignant vertebral fractures in this series.

TL;DR: Molecular MR imaging with the fibrin-targeted contrast-agent EP-2104R allows selective visualization of acute coronary, cardiac, and pulmonary thrombi.